Ciaffoni Joseph's most recent trade in Collegium Pharmaceutical Inc was a trade of 179,734 Common Stock done . Disclosure was reported to the exchange on Feb. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc | Ciaffoni Joseph | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 179,734 | 573,734 (1%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 119,000 | 394,000 (1%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.70 per share. | 12 Feb 2024 | 81,422 | 444,867 (1%) | 0% | 33.7 | 2,743,921 | Common Stock |
| Collegium Pharmaceutical Inc | Ciaffoni Joseph | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.70 per share. | 12 Feb 2024 | 47,445 | 526,289 (1%) | 0% | 33.7 | 1,598,897 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 4,357 | 16,875 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Ciaffoni Joseph | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.34 per share. | 21 Dec 2023 | 4,357 | 279,357 (0%) | 0% | 21.3 | 92,978 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.38 per share. | 21 Dec 2023 | 4,357 | 275,000 (0%) | 0% | 30.4 | 132,377 | Common Stock |
| Collegium Pharmaceutical Inc | Ciaffoni Joseph | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.34 per share. | 18 Dec 2023 | 27,798 | 302,798 (0%) | 0% | 21.3 | 593,209 | Common Stock |
| Collegium Pharmaceutical Inc | Ciaffoni Joseph | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2023 | 27,798 | 62,202 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.04 per share. | 18 Dec 2023 | 27,798 | 275,000 (0%) | 0% | 30.0 | 834,935 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2023 | 26,454 | 21,232 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.34 per share. | 18 Dec 2023 | 26,454 | 301,454 (0%) | 0% | 21.3 | 564,528 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.40 per share. | 18 Dec 2023 | 26,454 | 275,000 (0%) | 0% | 30.4 | 804,210 | Common Stock |
| Collegium Pharmaceutical Inc | Ciaffoni Joseph | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2023 | 14,516 | 47,686 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Ciaffoni Joseph | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 18 Dec 2023 | 14,516 | 275,000 (0%) | 0% | 30.0 | 435,942 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.34 per share. | 18 Dec 2023 | 14,516 | 289,516 (0%) | 0% | 21.3 | 309,771 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.09 per share. | 01 Jun 2023 | 31,272 | 306,272 (0%) | 0% | 22.1 | 690,758 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.58 per share. | 01 Jun 2023 | 30,272 | 276,000 (0%) | 0% | 21.6 | 653,173 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.25 per share. | 01 Jun 2023 | 1,000 | 275,000 (0%) | 0% | 22.3 | 22,251 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.87 per share. | 30 May 2023 | 31,272 | 337,544 (0%) | 0% | 21.9 | 683,797 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 30 May 2023 | 31,271 | 368,816 (1%) | 0% | 21.9 | 684,907 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 137,694 | 503,944 (1%) | 0% | - | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 117,500 | 366,250 (1%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.75 per share. | 10 Feb 2023 | 59,736 | 400,087 (1%) | 0% | 26.8 | 1,597,938 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.75 per share. | 10 Feb 2023 | 44,121 | 459,823 (1%) | 0% | 26.8 | 1,180,237 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 11,250 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.88 per share. | 10 Feb 2023 | 11,250 | 400,087 (1%) | 0% | 26.9 | 302,400 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.90 per share. | 10 Feb 2023 | 11,250 | 411,337 (1%) | 0% | 15.9 | 178,875 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.65 per share. | 22 Dec 2022 | 1,804 | 249,150 (0%) | 0% | 23.7 | 42,665 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.19 per share. | 22 Dec 2022 | 400 | 248,750 (0%) | 0% | 24.2 | 9,676 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 22 Dec 2022 | 147 | 250,954 (0%) | 0% | 23 | 3,381 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 22 Dec 2022 | 110 | 251,101 (0%) | 0% | 23 | 2,530 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.07 per share. | 19 Dec 2022 | 9,375 | 258,544 (0%) | 0% | 23.1 | 216,281 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.11 per share. | 19 Dec 2022 | 7,333 | 251,211 (0%) | 0% | 23.1 | 169,466 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.01 per share. | 19 Dec 2022 | 1,134 | 267,919 (0%) | 0% | 23.0 | 26,093 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.47 per share. | 01 Dec 2022 | 76,653 | 323,453 (0%) | 0% | 22.5 | 1,722,393 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 76,653 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.90 per share. | 01 Dec 2022 | 76,653 | 400,106 (1%) | 0% | 15.9 | 1,218,783 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.07 per share. | 01 Dec 2022 | 54,400 | 269,053 (0%) | 0% | 23.1 | 1,255,008 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 28 Nov 2022 | 43 | 323,453 (0%) | 0% | 22 | 946 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.91 per share. | 28 Nov 2022 | 43 | 323,496 (0%) | 0% | 15.9 | 684 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 43 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.91 per share. | 22 Nov 2022 | 65 | 323,518 (0%) | 0% | 15.9 | 1,034 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2022 | 65 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 22 Nov 2022 | 65 | 323,453 (0%) | 0% | 22 | 1,430 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 1,989 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.02 per share. | 18 Nov 2022 | 1,989 | 323,453 (0%) | 0% | 22.0 | 43,798 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.90 per share. | 18 Nov 2022 | 1,989 | 325,442 (0%) | 0% | 15.9 | 31,625 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.16 per share. | 01 Jul 2022 | 1,394 | 323,453 (0%) | 0% | 18.2 | 25,315 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.37 per share. | 01 Mar 2022 | 65,083 | 335,858 (0%) | 0% | 18.4 | 1,195,575 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 01 Mar 2022 | 11,011 | 324,847 (0%) | 0% | 19.0 | 209,649 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 125,000 | 388,904 (1%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 65,034 | 453,938 (1%) | 0% | - | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.63 per share. | 10 Feb 2022 | 28,843 | 400,941 (1%) | 0% | 17.6 | 508,502 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.63 per share. | 10 Feb 2022 | 24,154 | 429,784 (1%) | 0% | 17.6 | 425,835 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.68 per share. | 03 Jan 2022 | 1,090 | 263,904 (0%) | 0% | 18.7 | 20,361 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.03 per share. | 10 Aug 2021 | 1,386 | 264,994 (0%) | 0% | 19.0 | 26,376 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.99 per share. | 01 Jul 2021 | 1,394 | 266,380 (0%) | 0% | 24.0 | 33,442 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 01 Jun 2021 | 16,205 | 289,840 (0%) | 0% | 8.2 | 133,205 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 16,205 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.33 per share. | 01 Jun 2021 | 10,829 | 273,635 (0%) | 0% | 23.3 | 252,641 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.81 per share. | 01 Jun 2021 | 5,861 | 267,774 (0%) | 0% | 22.8 | 133,689 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.93 per share. | 01 Jun 2021 | 5,376 | 284,464 (0%) | 0% | 22.9 | 123,272 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.90 per share. | 01 Jun 2021 | 4,672 | 273,635 (0%) | 0% | 22.9 | 106,989 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.56 per share. | 01 Mar 2021 | 54,959 | 288,116 (0%) | 0% | 22.6 | 1,239,875 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 01 Mar 2021 | 48,616 | 343,075 (1%) | 0% | 8.2 | 399,624 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 48,616 | 16,205 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.30 per share. | 01 Mar 2021 | 9,809 | 278,307 (0%) | 0% | 23.3 | 228,550 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.95 per share. | 10 Feb 2021 | 15,288 | 294,459 (0%) | 0% | 26.0 | 396,724 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.95 per share. | 10 Feb 2021 | 8,498 | 309,747 (0%) | 0% | 25.9 | 220,523 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 105,000 | 289,256 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 28,989 | 318,245 (0%) | 0% | - | Common Stock | |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.03 per share. | 04 Jan 2021 | 1,090 | 184,256 (0%) | 0% | 20.0 | 21,833 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.49 per share. | 30 Nov 2020 | 4,672 | 185,346 (0%) | 0% | 18.5 | 86,385 | Common Stock |
| Collegium Pharmaceutical Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.89 per share. | 10 Aug 2020 | 1,386 | 190,018 (0%) | 0% | 18.9 | 26,182 | Common Stock |